ASH 48th (2006)

Title Content type
Empirical Versus Pre-Emptive Antifungal Therapy in High-Risk Febrile Neutropenic Patients: An Economic Analysis. (click for details)
Outcomes of Patients with Hematological Malignancies Admitted to Critical Care. (click for details)
Stem Cell Transplantation from HLA-Identical Siblings Versus Alternative Donors in ß-Thalassemia Diseases. (click for details)
Retrospective Analysis of Fractionated High-Dose Melphalan (F-MEL) and Bortezomib-Thalidomide-Dexamethasone (VTD) with Autotransplant (AT) Support for Advanced and Refractory Multiple Myeloma (AR-MM). (click for details)
Prophylactic Antibiotics Reduce Morbidity from Septicemia during Intensive Treatment for Pediatric Acute Myelogenous Leukemia. (click for details)
Immune Reconstruction Inflammatory Syndrome (IRIS) with Invasive Aspergillosis (IA) in Patients (pts) with Hematological Cancer (Hem-Ca): Clinical and Research Implications. (click for details)
Empiric or Presumptive Anti-Aspergillus Treatments for Allogeneic Hematopoietic Stem Cell Transplant Recipients with Sustained Febrile Neutropenia. (click for details)
Efficacy and Safety of Micafungin, an Echinocandin Antifungal Agent on Systemic Fungal Infections in Patients with Hematological Disorders. (click for details)
Fludarabine, Ara-C, Novantrone and Dexamethasone Plus Campath-1H for the Treatment of Patients with Chronic Lymphocytic Leukemia (CLL) and Adverse Clinical and Biologic Prognostic Features. (click for details)
Fludarabine, Mitoxantrone and Dexamethasone for the First Line Treatment of Patients with Indolent Non-Hodgkin Lymphoma (NHL): GATLA First Interim Report (Grupo Argentino de Tratamiento de la Leucemia Aguda). (click for details)


Subscribe to ASH 48th (2006)